This story was first published in digitalhealth.net

A study published in The Lancet Psychiatry has called for the trial of ketamine to treat depression to be rolled out as a mainstream treatment.
Dr Rupert McShane, who has led a trial in Oxford, since 2011 has said that ketamine can work on tens of thousands of patients who have depression but have not benefitted from other drugs.
In the trial, of the 101 people taking part who had failed to find a successful depression treatment, 42 of them responded to the ketamine.
Ketamine is currently licensed to be used as an anaesthetic but has a reputation as an illegal party drug. The dosage of ketamine used in the depression treatment is much lower than that used by people for recreational use.
McShane said: “We think that patients' treatment should be in specialist centres and formally tracked in national or international registries. This will help us to pick up any safety or abuse problems with longer term use and narrow down what dose, frequency, route and durations of treatment works best."
Commenting on the paper, Prof Allan Young, from the The Royal College of Psychiatrists, said: “Before ketamine can be recommended for use in clinical practice, extensive research is required to understand how to optimally use ketamine for treating depression.
"The Royal College of Psychiatrists has concerns for patient safety and hence recommends mental health practitioners to proceed with caution when treating patients with ketamine."
This story was first published in digitalhealth.net
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly